3-hydroxyflavone has been researched along with Anterior Cerebral Circulation Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, TV; Birkenmayer, G; Gelderblom, M; Gerloff, C; Lewerenz, J; Leypoldt, F; Ludewig, P; Magnus, T; Maher, P; Orozco, D; Thundyil, J; Tolosa, E | 1 |
1 other study(ies) available for 3-hydroxyflavone and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice.
Topics: Animals; Anti-Inflammatory Agents; Brain Infarction; Cell Line; Dendritic Cells; Disease Models, Animal; Flavonoids; Flavonols; Humans; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 4; Mice; Microglia; Neuroprotective Agents; Phosphorylation; Reperfusion Injury; Time Factors; Tumor Necrosis Factor-alpha | 2012 |